GLP-1/GIP agonists: complementing obesity treatment to achieve better results
Obesity is a chronic, complex and multifactorial condition, recognised by the World Health Organisation. In Portugal, a large proportion of the adult population is overweight or obese, with around 2 in 10 adults being obese, according to data from public health. In recent years, innovative medicines such as semaglutide (Wegovy®)…
Read More